FAMILIAL PARTIAL LIPODYSTROPHY
Clinical trials for FAMILIAL PARTIAL LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL PARTIAL LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for FAMILIAL PARTIAL LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for rare fat disorder: expanded access to metreleptin offered
Disease control AVAILABLEThis expanded access program provides metreleptin (MyaLept) to patients with familial partial lipodystrophy who also have diabetes or very high triglycerides. Metreleptin is already approved for generalized lipodystrophy, but this program aims to help those with the partial form.…
Matched conditions: FAMILIAL PARTIAL LIPODYSTROPHY
Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Hope for rare fat disorder: new drug shows promise in Long-Term trial
Disease control Recruiting nowThis study looks at the long-term safety and effectiveness of a daily injection called metreleptin for people with familial partial lipodystrophy, a rare condition where fat is distributed abnormally. About 24 participants who completed a previous study will receive the drug for …
Matched conditions: FAMILIAL PARTIAL LIPODYSTROPHY
Phase: PHASE3 • Sponsor: Amryt Pharma • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could mounjaro help a rare fat disorder? new trial aims to find out
Disease control Recruiting nowThis phase 2 trial tests whether tirzepatide (Mounjaro), a drug already approved for diabetes and weight loss, can improve blood sugar and lower triglycerides in people with partial lipodystrophy—a rare condition where the body loses fat tissue. Researchers will compare tirzepati…
Matched conditions: FAMILIAL PARTIAL LIPODYSTROPHY
Phase: PHASE2 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 26, 2026 14:27 UTC
-
Fat storage mystery: new study probes rare disease
Knowledge-focused Recruiting nowThis study looks at how fat is stored in people with familial partial lipodystrophy (FPLD), a condition that can lead to diabetes and heart disease. Researchers will compare fat tissue from people with FPLD and healthy volunteers. Participants drink special water and get infusion…
Matched conditions: FAMILIAL PARTIAL LIPODYSTROPHY
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC